Tag: Europe
-
Novartis Licenses Biomaterial for Cancer Immunotherapy
Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer.
-
More Accurate Thyroid Cancer Screening Technology Advances
A European initiative is developing a laser-enhanced technology to better distinguish between cancerous and benign thyroid nodules, for catching thyroid cancer earlier as well as preventing unnecessary surgeries.
-
Self-Service A.I. Offered for Pathologists
A company in Finland is beginning a service that allows pathologists and researchers the ability to design their own artificial intelligence algorithms without writing code, for analyzing visual images of tissue samples.
-
Evotec Acquiring Sanofi Infectious Disease Portfolio
Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France.
-
Breathalyzer Biopsy Company Gains $15M in New Funds
A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital.
-
Trials Test Antibodies to Prevent Hospital Infections
Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics.
-
Precision Cancer Drug Shown Effective in Adults, Children
Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs.
-
Trial Shows Treatment Desensitizes Peanut Allergies
A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.
-
Neuro Therapy Company Spins-Off, Gains $20.8M Funding
A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors.